BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

​ Conditions: Metastatic Pancreatic Adenocarcinoma; Recurrent Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8

Interventions: Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Gemcitabine; Biological: Imzokitug; Procedure: Magnetic Resonance Imaging; Drug: Nab-paclitaxel; Biological: Nivolumab

Sponsors: Mayo Clinic

Not yet recruiting Conditions: Metastatic Pancreatic Adenocarcinoma; Recurrent Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8
Interventions: Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Gemcitabine; Biological: Imzokitug; Procedure: Magnetic Resonance Imaging; Drug: Nab-paclitaxel; Biological: Nivolumab
Sponsors: Mayo Clinic
Not yet recruiting